BeOne Medicines Ltd. (SHA:688235)
China
· Delayed Price · Currency is CNY 235.56
-19.16 (-7.52%)
Jun 27, 2025, 2:45 PM CST
BeOne Medicines Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -392.37 | -644.79 | -881.71 | -2,004 | -1,458 | -1,625 | Upgrade
|
Depreciation & Amortization | 174.55 | 167.03 | 83.94 | 63.05 | 45.49 | 31.79 | Upgrade
|
Other Amortization | 4.72 | 4.73 | 3.74 | 3.23 | 0.97 | - | Upgrade
|
Asset Writedown & Restructuring Costs | -19.9 | -13.23 | -8.49 | -27.74 | -28.99 | -4.49 | Upgrade
|
Loss (Gain) From Sale of Investments | 24.02 | 24.02 | 16.22 | 22 | -7.63 | -11.83 | Upgrade
|
Stock-Based Compensation | 448.43 | 441.62 | 367.62 | 303.16 | 240.71 | 183.48 | Upgrade
|
Other Operating Activities | 52.4 | 37.15 | -368.23 | 11.11 | 26.89 | -8.03 | Upgrade
|
Change in Accounts Receivable | -281.28 | -329.44 | -188.31 | 304.11 | -423.02 | 10.36 | Upgrade
|
Change in Inventory | -50.25 | -91.5 | -140.95 | -56.69 | -153.33 | -58.91 | Upgrade
|
Change in Accounts Payable | 43.63 | 121.5 | 21.48 | -4.35 | 20.01 | 95.84 | Upgrade
|
Change in Unearned Revenue | 0.63 | 0.63 | -255.59 | -151.82 | 407.7 | - | Upgrade
|
Change in Other Net Operating Assets | 207.43 | 141.64 | 192.82 | 41.14 | 30.3 | 103.29 | Upgrade
|
Operating Cash Flow | 212.02 | -140.63 | -1,157 | -1,497 | -1,299 | -1,283 | Upgrade
|
Capital Expenditures | -392.49 | -492.66 | -561.9 | -325.43 | -262.94 | -117.51 | Upgrade
|
Sale (Purchase) of Intangibles | -60 | -36.47 | -34.37 | -143.67 | -51.91 | -109.5 | Upgrade
|
Investment in Securities | -17.21 | -16.35 | 658.34 | 1,548 | 955.51 | -2,939 | Upgrade
|
Other Investing Activities | 9.24 | -2.86 | -2.08 | -1.49 | - | -2.03 | Upgrade
|
Investing Cash Flow | -460.46 | -548.35 | 60 | 1,077 | 640.66 | -3,168 | Upgrade
|
Short-Term Debt Issued | - | 868.27 | 661.53 | 313.77 | 406.45 | 323.7 | Upgrade
|
Long-Term Debt Issued | - | 9.05 | 22.5 | 37.37 | 16.84 | 110.21 | Upgrade
|
Total Debt Issued | 806.24 | 877.32 | 684.03 | 351.15 | 423.29 | 433.91 | Upgrade
|
Short-Term Debt Repaid | - | -704.22 | -309.58 | -417.08 | -321.75 | -12.25 | Upgrade
|
Long-Term Debt Repaid | - | -28.03 | -13.69 | - | - | -132.06 | Upgrade
|
Total Debt Repaid | -905.8 | -732.25 | -323.27 | -417.08 | -321.75 | -144.31 | Upgrade
|
Net Debt Issued (Repaid) | -99.56 | 145.08 | 360.77 | -65.94 | 101.53 | 289.6 | Upgrade
|
Issuance of Common Stock | 93.94 | 45.37 | 55.71 | 46.96 | 3,535 | 4,325 | Upgrade
|
Other Financing Activities | 3 | 3 | - | - | - | 588.11 | Upgrade
|
Financing Cash Flow | -2.62 | 193.45 | 416.48 | -18.97 | 3,637 | 5,203 | Upgrade
|
Foreign Exchange Rate Adjustments | -25.79 | -51.71 | -8.08 | -69.38 | 14.04 | 18.23 | Upgrade
|
Net Cash Flow | -276.85 | -547.24 | -689.05 | -507.85 | 2,993 | 769.23 | Upgrade
|
Free Cash Flow | -180.47 | -633.29 | -1,719 | -1,822 | -1,562 | -1,401 | Upgrade
|
Free Cash Flow Margin | -4.32% | -16.62% | -69.93% | -128.68% | -132.76% | -453.57% | Upgrade
|
Free Cash Flow Per Share | -1.70 | -6.01 | -16.47 | -17.67 | -16.83 | -16.78 | Upgrade
|
Cash Interest Paid | 51.94 | 51.18 | 19.75 | 25.17 | 29.97 | 44.13 | Upgrade
|
Cash Income Tax Paid | 76.26 | 69.43 | 56 | 29.5 | 15.7 | 10.6 | Upgrade
|
Levered Free Cash Flow | -120.68 | -367 | -1,274 | -943.69 | -1,204 | -752.29 | Upgrade
|
Unlevered Free Cash Flow | -109.09 | -357.79 | -1,271 | -931.75 | -1,186 | -741.06 | Upgrade
|
Change in Net Working Capital | 99.08 | 86.57 | 375.07 | -286.45 | 259.47 | -306.73 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.